CNBC
cnbc.com
did:plc:m7ks2xhfuku7errrtfjux2lg
This biopharma stock could more than double on oral eczema treatment, Goldman Sachs says https://cnb.cx/4cQodV1
2026-04-17T16:35:08.950Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.